Microglial burden, activation and dystrophy patterns in frontotemporal lobar degeneration
Ione O C Woollacott1, Christina E Toomey2,3, Catherine Strand2
1Dementia Research Centre, Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.
Journal of Neuroinflammation
|August 12, 2020
Summary
Microglial dysfunction is observed in frontotemporal lobar degeneration (FTLD) and Alzheimer
Area of Science:
- Neuroscience
- Neuropathology
- Immunology
Background:
- Microglial dysfunction is linked to frontotemporal lobar degeneration (FTLD).
- While microglial changes are known in Alzheimer's disease (AD), they are less understood in FTLD.
- This study investigates microglial burden, activation, and dystrophy in FTLD, AD, and controls.
Purpose of the Study:
- To examine regional patterns of microglial burden, activation, and dystrophy in sporadic and genetic FTLD, AD, and control brains.
- To compare microglial characteristics across different FTLD subtypes (FTLD-tau, FTLD-TDP, FTLD-FUS) and genetic forms.
- To analyze microglial differences between grey and white matter within each disease group.
Main Methods:
- Immunohistochemistry using markers for phagocytic (CD68), antigen-presenting (CR3/43), and general microglia (Iba1).
- Quantitative assessment of microglial burden and activation (morphology).
- Semi-quantitative and qualitative assessment of microglial dystrophy, rod-shaped, and hypertrophic morphology in frontal and temporal grey and white matter.
Main Results:
- FTLD and AD cases showed higher microglial burden than controls, with often unchanged activation.
- Microglial burden was higher in white matter, while activation was greater in grey matter.
- Microglial dystrophy was more severe in FTLD and AD, particularly in white matter and in FTLD linked to GRN mutations; regional variations and subtype-specific morphologies were observed.
Conclusions:
- Microglial involvement in FTLD is regionally variable and linked to specific disease mechanisms.
- Findings support further research into microglial dysfunction in FTLD models.
- Consideration of anti-senescence therapies for FTLD is warranted.
Keywords:
DystrophyFrontotemporal dementiaFrontotemporal lobar degenerationMicrogliaNeuroinflammationProgranulinMore Related Videos
12:28Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
18.0K
10:40Immunofluorescence Staining Using IBA1 and TMEM119 for Microglial Density, Morphology and Peripheral Myeloid Cell Infiltration Analysis in Mouse Brain
Published on: October 27, 2019
34.2K
Related Concept Videos
Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
